STL1267 inhibits myofibroblast differentiation in a TGFβ1-driven human lung fibroblast model
- 1 March 2026
- journal article
- Published by American Physiological Society in American Journal of Physiology-Cell Physiology
- Vol. 330 (3) , C571-C589
Abstract
This study introduces a novel in vitro adenovirus-based model of persistent TGFβ1 signaling in normal human lung fibroblasts to mimic chronic fibrosis. Using this model, we show that the next-generation REV-ERBα agonist STL1267 robustly inhibits myofibroblast differentiation and ECM gene expression. STL1267 outperforms Food and Drug Administration-approved antifibrotic drugs and modulates immune and circadian signaling pathways, supporting its potential as a promising circadian-based therapeutic strategy for pulmonary fibrosis.Keywords
Funding Information
- National Heart, Lung, and Blood Institute (R01 HL142543)
- National Institute on Aging (AG060769)
- National Institute of General Medical Sciences (P20 GM103418)
- University of Kansas Medical Center (Lied Pre-Clinical Grant)
- School of Medicine, University of Kansas (Internal Medicine Start-Up Funds)
- National Center for Advancing Translational Sciences (UL1TR002366 (BERD Voucher))
This publication has 50 references indexed in Scilit:
- Development of radioligand binding assays for REV-ERBα and REV-ERBβAnalytical Biochemistry, 2025
- Rev-erbα agonists suppresses TGFβ1-induced fibroblast-to-myofibroblast transition and pro-fibrotic phenotype in human lung fibroblastsBiochemical and Biophysical Research Communications, 2023
- Structural basis of synthetic agonist activation of the nuclear receptor REV-ERBNature Communications, 2022
- Circadian molecular clock disruption in chronic pulmonary diseasesTrends in Molecular Medicine, 2022
- Gene Set Knowledge Discovery with EnrichrCurrent Protocols, 2021
- Two-Way Conversion between Lipogenic and Myogenic Fibroblastic Phenotypes Marks the Progression and Resolution of Lung FibrosisCell Stem Cell, 2017
- Transcriptional architecture of the mammalian circadian clockNature Reviews Genetics, 2016
- The circadian gene Rev-erbα improves cellular bioenergetics and provides preconditioning for protection against oxidative stressFree Radical Biology and Medicine, 2016
- Rev-erb-α modulates skeletal muscle oxidative capacity by regulating mitochondrial biogenesis and autophagyNature Medicine, 2013
- Regulation of circadian behaviour and metabolism by synthetic REV-ERB agonistsNature, 2012